JP2020519250A5 - - Google Patents

Download PDF

Info

Publication number
JP2020519250A5
JP2020519250A5 JP2019558571A JP2019558571A JP2020519250A5 JP 2020519250 A5 JP2020519250 A5 JP 2020519250A5 JP 2019558571 A JP2019558571 A JP 2019558571A JP 2019558571 A JP2019558571 A JP 2019558571A JP 2020519250 A5 JP2020519250 A5 JP 2020519250A5
Authority
JP
Japan
Prior art keywords
fusion polypeptide
amino acid
seq
leu
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019558571A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020519250A (ja
Filing date
Publication date
Priority claimed from GBGB1706781.0A external-priority patent/GB201706781D0/en
Application filed filed Critical
Publication of JP2020519250A publication Critical patent/JP2020519250A/ja
Publication of JP2020519250A5 publication Critical patent/JP2020519250A5/ja
Priority to JP2022202078A priority Critical patent/JP2023027315A/ja
Pending legal-status Critical Current

Links

JP2019558571A 2017-04-28 2018-04-27 副甲状腺ホルモン融合ポリペプチド Pending JP2020519250A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022202078A JP2023027315A (ja) 2017-04-28 2022-12-19 副甲状腺ホルモン融合ポリペプチド

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1706781.0 2017-04-28
GBGB1706781.0A GB201706781D0 (en) 2017-04-28 2017-04-28 Parathyroid hormone fusion polypeptide
PCT/GB2018/051120 WO2018197895A2 (en) 2017-04-28 2018-04-27 Parathyroid hormone fusion polypeptide

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022202078A Division JP2023027315A (ja) 2017-04-28 2022-12-19 副甲状腺ホルモン融合ポリペプチド

Publications (2)

Publication Number Publication Date
JP2020519250A JP2020519250A (ja) 2020-07-02
JP2020519250A5 true JP2020519250A5 (cg-RX-API-DMAC7.html) 2021-06-10

Family

ID=59011076

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019558571A Pending JP2020519250A (ja) 2017-04-28 2018-04-27 副甲状腺ホルモン融合ポリペプチド
JP2022202078A Pending JP2023027315A (ja) 2017-04-28 2022-12-19 副甲状腺ホルモン融合ポリペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022202078A Pending JP2023027315A (ja) 2017-04-28 2022-12-19 副甲状腺ホルモン融合ポリペプチド

Country Status (7)

Country Link
US (2) US11344606B2 (cg-RX-API-DMAC7.html)
EP (1) EP3609913A2 (cg-RX-API-DMAC7.html)
JP (2) JP2020519250A (cg-RX-API-DMAC7.html)
CN (1) CN110546159B (cg-RX-API-DMAC7.html)
CA (1) CA3061088A1 (cg-RX-API-DMAC7.html)
GB (1) GB201706781D0 (cg-RX-API-DMAC7.html)
WO (1) WO2018197895A2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201706781D0 (en) * 2017-04-28 2017-06-14 Univ Sheffield Parathyroid hormone fusion polypeptide
IL284533B2 (en) * 2019-01-11 2024-02-01 Radius Health Inc Methods for detecting antibodies to neutralizing thyroid hormone (PTH) and thyroid hormone-related peptide (PTHRP) analog
CN111876388A (zh) * 2020-07-24 2020-11-03 赛瑞诚(苏州)生物科技有限公司 一种骨和骨组织靶向外泌体及其制备方法和应用
CN118126197B (zh) * 2024-03-19 2025-02-25 康众(广东)生物医药有限公司 一种重组pth融合蛋白及其构建方法与应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770623B1 (en) 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
JPH11285388A (ja) 1998-04-03 1999-10-19 Jcr Pharmaceuticals Co Ltd キメラレセプター発現細胞とその用途
WO2001081408A2 (en) 2000-04-21 2001-11-01 New England Medical Center G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same
MX2007001180A (es) 2004-07-26 2007-04-13 Asterion Ltd Enlazantes.
KR100700869B1 (ko) 2005-06-03 2007-03-29 재단법인 목암생명공학연구소 Pth, 완충제 및 안정제를 포함하는 안정한 pth조성물
ES2583002T3 (es) 2007-04-09 2016-09-16 The Board Of Trustees Of The University Of Arkansas Proteínas de fusión de un dominio de enlazamiento a colágeno y hormona paratiroidea
GB0717985D0 (en) 2007-07-20 2007-10-24 Asterion Ltd Growth hormone fusion proteins
WO2010111617A2 (en) 2009-03-27 2010-09-30 Van Andel Research Institute Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
WO2011101284A1 (en) 2010-02-16 2011-08-25 Novo Nordisk A/S Factor viii fusion protein
CN103002906B (zh) 2010-05-13 2017-12-29 总医院有限公司 甲状旁腺激素类似物及其应用
GB201104285D0 (en) * 2011-03-15 2011-04-27 Asterion Ltd Modified receptor fusion proteins
US9579273B2 (en) 2011-12-14 2017-02-28 The Kitasato Institute Delivery of therapeutic agents by a collagen binding protein
WO2013120060A1 (en) 2012-02-09 2013-08-15 The Board Of Trustees Of The University Of Arkansas Delivery of therapeutic agents by a collagen binding protein
US20150011473A1 (en) 2012-01-20 2015-01-08 Lupin Limited Stabilized pth formulation
CA2919477A1 (en) * 2013-07-31 2015-02-05 Dana-Farber Cancer Institute, Inc. Compositions and methods for modulating thermogenesis using pth-related and egf-related molecules
WO2016183297A1 (en) 2015-05-12 2016-11-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Aav isolate and fusion protein comprising nerve growth factor signal peptide and parathyroid hormone
GB201706781D0 (en) * 2017-04-28 2017-06-14 Univ Sheffield Parathyroid hormone fusion polypeptide

Similar Documents

Publication Publication Date Title
PE20231309A1 (es) Agonistas duales glp-1/gip
US5693616A (en) Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
CA2246733C (en) Use of a pharmaceutical composition comprising an appetite-suppressing peptide
JP2011509269A5 (cg-RX-API-DMAC7.html)
JP5780958B2 (ja) ハロゲン安定化インスリン
EP2970511B1 (en) Insulin-incretin conjugates
CA2434237A1 (en) Glp-1 fusion proteins
CN108271356A (zh) 肠降血糖素-胰岛素缀合物
JP2019504057A5 (cg-RX-API-DMAC7.html)
AU2025202650A1 (en) ELP fusion proteins for controlled and sustained release
RU2010133231A (ru) Новые производные инсулина с чрезвычайно замедленным профилем время/действие
CZ289343B6 (cs) Inzulinový derivát a farmaceutický prostředek pro léčení diabetes
US7057012B1 (en) PTH functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules
US20220218790A1 (en) Parathyroid hormone fusion polypeptide
CA2223832A1 (en) Method for the treatment of corticosteroid induced osteopenia
WO2013110069A1 (en) Glutamic acid-stabilized insulin analogues
Shuldiner et al. Insulin
JP2010043001A (ja) Glp−1誘導体とその用途
US9725493B2 (en) N-terminal truncated insulin analogues
CN1134452C (zh) 新的维生素d受体相关多肽、编码其的核苷酸序列及其用途
Kühn-Wache et al. Analogs of glucose-dependent insulinotropic polypeptide with increased dipeptidyl peptidase IV resistance
RU2011131714A (ru) Аналоги glp-1 и их использования
RU2024106867A (ru) Аффимеры, связывающиеся с неонатальным Fc рецептором
CA2040649A1 (en) Growth hormone releasing factor analogs
Sami et al. Overproduction of a gastrointestinal hormone, secretin, in Escherichia coli cells and its chemical characterization.